Dramatic Response to Pazopanib in a Patient With Metastatic Malignant Granular Cell Tumor

被引：19

作者：

Conley, Anthony P. ^{[1
]}

Koplin, Stephanie ^{[2
]}

Caracciollo, Jamie T. ^{[1
]}

Reed, Damon R. ^{[1
]}

Webber, Nicolas P. ^{[2
]}

Attia, Steven ^{[3
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA

[2] Aurora Canc Care, Milwaukee, WI USA

[3] Mayo Clin Florida, Jacksonville, FL USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 32期

关键词：

GROWTH-FACTOR PATHWAY; POTENT ANTITUMOR; SOFT-TISSUE; ANGIOGENESIS; INHIBITOR;

D O I：

10.1200/JCO.2012.47.1078

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E107 / E110

页数：4

共 11 条

[1] Vascular Endothelial Growth Factor Pathway Polymorphisms as Prognostic and Pharmacogenetic Factors in Cancer: A Systematic Review and Meta-analysis [J].

Eng, Lawson ;

Azad, Abul Kalam ;

Habbous, Steven ;

Pang, Vincent ;

Xu, Wei ;

Maitland-van der Zee, Anke H. ;

Savas, Sevtap ;

Mackay, Helen J. ;

Amir, Eitan ;

Liu, Geoffrey .

CLINICAL CANCER RESEARCH, 2012, 18 (17) :4526-4537

[2]

Enzinger RM, 1995, SOFT TISSUE TUMORS, P864

[3] Malignant granular cell tumor of soft tissue - Diagnostic criteria and clinicopathologic correlation [J].

Fanburg-Smith, JC ;

Meis-Kindblom, JM ;

Fante, R ;

Kindblom, LG .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (07) :779-794

[4]

FISHER ER, 1962, CANCER-AM CANCER SOC, V15, P936, DOI 10.1002/1097-0142(196209/10)15:5<936::AID-CNCR2820150509>3.0.CO

[5]

2-F

[6] Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis [J].

Hicklin, DJ ;

Ellis, LM .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (05) :1011-1027

[7]

Jefferson E, FDA APPROVES VOTRIEN

[8] Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity [J].

Kumar, Rakesh ;

Knick, Victoria B. ;

Rudolph, Sharon K. ;

Johnson, Jennifer H. ;

Crosby, Renae M. ;

Crouthamel, Ming-Chih ;

Hopper, Teresa M. ;

Miller, Charles G. ;

Harrington, Laura E. ;

Onori, James A. ;

Mullin, Robert J. ;

Gilmer, Tona M. ;

Truesdale, Anne T. ;

Epperly, Andrea H. ;

Boloor, Amogh ;

Stafford, Jeffrey A. ;

Luttrell, Deirdre K. ;

Cheung, Mui .

MOLECULAR CANCER THERAPEUTICS, 2007, 6 (07) :2012-2021

[9] Discovery of N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays [J].

Lombardo, LJ ;

Lee, FY ;

Chen, P ;

Norris, D ;

Barrish, JC ;

Behnia, K ;

Castaneda, S ;

Cornelius, LAM ;

Das, J ;

Doweyko, AM ;

Fairchild, C ;

Hunt, JT ;

Inigo, I ;

Johnston, K ;

Kamath, A ;

Kan, D ;

Klei, H ;

Marathe, P ;

Pang, SH ;

Peterson, R ;

Pitt, S ;

Schieven, GL ;

Schmidt, RJ ;

Tokarski, J ;

Wen, ML ;

Wityak, J ;

Borzilleri, RM .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (27) :6658-6661

[10] VEGF receptor signalling - in control of vascular function [J].

Olsson, AK ;

Dimberg, A ;

Kreuger, J ;

Claesson-Welsh, L .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (05) :359-371

← 1 2 →